232 related articles for article (PubMed ID: 36070463)
21. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
Bertot LC; Adams LA
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
[TBL] [Abstract][Full Text] [Related]
22. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
Wongjarupong N; Assavapongpaiboon B; Susantitaphong P; Cheungpasitporn W; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
BMC Gastroenterol; 2017 Dec; 17(1):149. PubMed ID: 29216833
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis.
Tabaeian SP; Rezapour A; Azari S; Martini M; Saran M; Behzadifar M; Shahabi S; Sayyad A; Tahernejad A; Bragazzi NL; Ehsanzadeh SJ; Behzadifar M
J Clin Exp Hepatol; 2024; 14(1):101209. PubMed ID: 38076354
[TBL] [Abstract][Full Text] [Related]
24. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.
Cao L; An Y; Liu H; Jiang J; Liu W; Zhou Y; Shi M; Dai W; Lv Y; Zhao Y; Lu Y; Chen L; Xia Y
BMC Med; 2024 Mar; 22(1):101. PubMed ID: 38448943
[TBL] [Abstract][Full Text] [Related]
25. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
[TBL] [Abstract][Full Text] [Related]
26. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.
Younossi ZM; Golabi P; Paik JM; Henry A; Van Dongen C; Henry L
Hepatology; 2023 Apr; 77(4):1335-1347. PubMed ID: 36626630
[TBL] [Abstract][Full Text] [Related]
27. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Ha J; Yim SY; Karagozian R
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2496-2507.e5. PubMed ID: 36442727
[TBL] [Abstract][Full Text] [Related]
28. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
[TBL] [Abstract][Full Text] [Related]
29. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Thongtan T; Deb A; Vutthikraivit W; Laoveeravat P; Mingbunjerdsuk T; Islam S; Islam E
Indian J Gastroenterol; 2022 Apr; 41(2):119-126. PubMed ID: 35318571
[TBL] [Abstract][Full Text] [Related]
30. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
[TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis.
Shea S; Lionis C; Kite C; Lagojda L; Uthman OA; Dallaway A; Atkinson L; Chaggar SS; Randeva HS; Kyrou I
Front Endocrinol (Lausanne); 2024; 15():1357664. PubMed ID: 38689730
[TBL] [Abstract][Full Text] [Related]
32. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease.
Tovoli F; Ferri S; Piscaglia F
Curr Pharm Des; 2020; 26(32):3909-3914. PubMed ID: 32348210
[TBL] [Abstract][Full Text] [Related]
34. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Vernon G; Baranova A; Younossi ZM
Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
[TBL] [Abstract][Full Text] [Related]
35. Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world.
Henry L; Paik J; Younossi ZM
Aliment Pharmacol Ther; 2022 Sep; 56(6):942-956. PubMed ID: 35880713
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040.
Ito T; Ishigami M; Zou B; Tanaka T; Takahashi H; Kurosaki M; Maeda M; Thin KN; Tanaka K; Takahashi Y; Itoh Y; Oniki K; Seko Y; Saruwatari J; Kawanaka M; Atsukawa M; Hyogo H; Ono M; Ogawa E; Barnett SD; Stave CD; Cheung RC; Fujishiro M; Eguchi Y; Toyoda H; Nguyen MH
Hepatol Int; 2021 Apr; 15(2):366-379. PubMed ID: 33580453
[TBL] [Abstract][Full Text] [Related]
37. The Global Prevalence of Nonalcoholic Fatty Liver Disease and its Association With Cancers: Systematic Review and Meta-Analysis.
Muhamad NA; Maamor NH; Leman FN; Mohamad ZA; Bakon SK; Abdul Mutalip MH; Rosli IA; Aris T; Lai NM; Abu Hassan MR
Interact J Med Res; 2023 Jul; 12():e40653. PubMed ID: 37467012
[TBL] [Abstract][Full Text] [Related]
38. Modelling NAFLD disease burden in four Asian regions-2019-2030.
Estes C; Chan HLY; Chien RN; Chuang WL; Fung J; Goh GB; Hu TH; Huang JF; Jang BK; Jun DW; Kao JH; Lee JW; Lin HC; Razavi-Shearer K; Seto WK; Wong GL; Wong VW; Razavi H
Aliment Pharmacol Ther; 2020 Apr; 51(8):801-811. PubMed ID: 32133676
[TBL] [Abstract][Full Text] [Related]
39. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
[TBL] [Abstract][Full Text] [Related]
40. Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.
Swain MG; Ramji A; Patel K; Sebastiani G; Shaheen AA; Tam E; Marotta P; Elkhashab M; Bajaj HS; Estes C; Razavi H
CMAJ Open; 2020; 8(2):E429-E436. PubMed ID: 32518095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]